News

UNICEF, April 2013

The newly launched Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea (GAPPD) calls for closer integration of efforts to prevent and treat these two diseases and sets ambitious targets to reduce child deaths and increase access to life-saving interventions.

Read the full press release.

RotaFlash, March 2013

Mexico’s Ministry of Health and the US Centers for Disease Control and Prevention have just released data that shows signficant reduction in rates of diarrheal disease across all regions of Mexico after the introduction of the rotavirus vaccine.

Read the full article

RotaFlash, February 2012

The World Health Organization (WHO) issued a new rotavirus vaccine position paper that reaffirms its global recommendation and clarifies the relaxation of age restrictions.

Read the full article

The Medical News, January 2013

A new study found that the prevalence of rotavirus in US adults declined by almost 50% during the peak seasons in 2008-2010, suggesting that routine rotavirus vaccination among children is indirectly protecting unvaccinated adults.

Read the full article.

IRIN, January 2013

Targeting areas known as "cholera hotbeds" could be key to reaching the Millennium Development Goal of reducing by half the number of people worldwide who lack access to safe water, according to aid groups.

Read the full article.

RotaFlash, January 2013

In an effort to address inequitable access to new vaccines, UNICEF has announced a tender to establish affordable and sustainable supplies of rotavirus, pneumococcal conjugate, and human papillomavirus vaccines for middle income countries.

Read the full article

Forbes, January 2013

In a recent in-depth interview conducted by the Skoll World Forum‘s Rahim Kanani, Executive Director of UNICEF Anthony Lake discussed the urgent need to create a commodities market of life-saving medicines in the developing world (including zinc and ORS), arguing that healthy children are good for business.

Read the full article

RotaFlash, December 2012

On December 6, Tanzania simultaneously launched vaccines against the primary causes of two of the leading childhood killers in Tanzania and worldwide – pneumonia and diarrhea. The launch took place in tandem with the GAVI Alliance Partners Forum, at which global experts and country leaders explored approaches to accelerate lives saved through immunization.

Read the full article.

PATH press release, November 2012

With a new grant from the Starbucks Foundation, PATH will address water, sanitation, and hygiene in coffee-growing communities in Tanzania.

Read the full press release.

Herald Online, November 2012

PATH’s Drug Development program announced today the completion of two phase 1 clinical studies for iOWH032—its investigational new drug to treat acute diarrhea caused by diseases such as cholera. Based on positive outcomes, iOWH032 will proceed into the next phase of clinical trials in Bangladesh in early 2013.

Read the full article

Read more here: http://www.heraldonline.com/2012/11/12/4407181/paths-drug-development-program.html#storylink=cpy
Syndicate content